CLINICAL_TRIALS trial_result · 2021-10-11

Clinical Trial Update: A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]

A study of olaratumab (LY3012207) in participants with advanced soft tissue sarcoma completed Phase 1 and Phase 2 trials; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-10-11